AE-induced ALI presents with pulmonary edema, high PVR, alveolar epithelial cell injury, pulmonary microvascular hyperpermeability, lung inflammation, and expression of pro-inflammatory cytokines, the NF-κB pathway, and NKCC1 (Fig. 8, left panel). The gene discussed is SLC12A2; the disease is inflammation.